Totally thrilled to be working with @drlaurajwaters.bsky.social and Dr. Magnus Gisslen again to summarize the top studies from #CROI2025. #IDSky #HIVSky Please sign up to join us! 31 March, 2025 medevents.se/events/ch2-2025
April 11, 2025 at 7:40 PM
Reposted by Mike Lin
Totally thrilled to be working with @drlaurajwaters.bsky.social and Dr. Magnus Gisslen again to summarize the top studies from #CROI2025. #IDSky #HIVSky Please sign up to join us! 31 March, 2025 medevents.se/events/ch2-2025
March 17, 2025 at 10:29 PM
Totally thrilled to be working with @drlaurajwaters.bsky.social and Dr. Magnus Gisslen again to summarize the top studies from #CROI2025. #IDSky #HIVSky Please sign up to join us! 31 March, 2025 medevents.se/events/ch2-2025
Which one is the best? I pick Seattle 2023😊☺️ The iconic HIV virus model should be preserved as a symbol of CROI.
March 14, 2025 at 11:34 PM
Which one is the best? I pick Seattle 2023😊☺️ The iconic HIV virus model should be preserved as a symbol of CROI.
Reposted by Mike Lin
Visited China for the first time. Highly recommended!
Some observations here, divided into HIV/ID and non-medical topics.
blogs.jwatch.org/hiv-id-obser...
Some observations here, divided into HIV/ID and non-medical topics.
blogs.jwatch.org/hiv-id-obser...
Notes from a Trip to China
Here are some observations from a recent trip to China, a country I’d never visited before. It was an 8-day trip related to my editor role at Clinical Infectious Diseases (there is a Chinese edition) ...
blogs.jwatch.org
December 28, 2024 at 10:27 AM
Visited China for the first time. Highly recommended!
Some observations here, divided into HIV/ID and non-medical topics.
blogs.jwatch.org/hiv-id-obser...
Some observations here, divided into HIV/ID and non-medical topics.
blogs.jwatch.org/hiv-id-obser...
Reposted by Mike Lin
With the publication of PURPOSE 2 for PrEP in @nejm.org, and the stellar results, I wonder what’s going to happen once it gets approved for this indication. Should be interesting, to say the least! blogs.jwatch.org/hiv-id-obser...
Who's Going to Get Lenacapavir for HIV Prevention?
At the International AIDS Conference this past summer, Dr. Linda-Gail Bekker brought down the house presenting the results of the PURPOSE 1 trial of twice-yearly injectable lenacapavir for prevention ...
blogs.jwatch.org
December 9, 2024 at 9:27 AM
With the publication of PURPOSE 2 for PrEP in @nejm.org, and the stellar results, I wonder what’s going to happen once it gets approved for this indication. Should be interesting, to say the least! blogs.jwatch.org/hiv-id-obser...